On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action Fund, which launched Jul. 9, to help address the significant global public health need for new antibiotics due to the rapid rise of antibiotic-resistant infections.